All Pharma News
Exicure and Bluejay Therapeutics Inc. Enter into a Patent License Agreement

Exicure and Bluejay Therapeutics Inc. Enter into a Patent License Agreement
BUSINESSWIRE
05 Feb 2024
Share Share
Exicure, Inc. Announces Appointment of New CEO and CFO

Exicure, Inc. Announces Appointment of New CEO and CFO
BUSINESSWIRE
23 Aug 2023
Share Share
Exicure`s CEO, CFO takes lead in search to bail out the biotech

Exicure`s CEO, CFO takes lead in search to bail out the biotech
James Waldron FIERCE BIOTECH
30 May 2023
Share Share
Exicure, Inc. Announces Support of CEO in its Exploration of Alternatives

Exicure, Inc. Announces Support of CEO in its Exploration of Alternatives
BUSINESSWIRE
26 May 2023
Share Share
Exicure, Inc. Announces Investment in Korean SNS Platform Cyworld

Exicure, Inc. Announces Investment in Korean SNS Platform Cyworld
BUSINESSWIRE
04 May 2023
Share Share
Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to BOD

Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to BOD
BUSINESSWIRE
27 Apr 2023
Share Share
Exicure considers transaction of some kind in death spiral

Exicure considers transaction of some kind in death spiral
Annalee Armstrong FIERCE BIOTECH
28 Mar 2023
Share Share
Exicure Reports Full Year 2022 Financial Results and Provides Corporate Update

Exicure Reports Full Year 2022 Financial Results and Provides Corporate Update
BUSINESSWIRE
27 Mar 2023
Share Share
Exicure Announces Termination of AbbVie and Ipsen Collaboration Agreements

Exicure Announces Termination of AbbVie and Ipsen Collaboration Agreements
BUSINESSWIRE
15 Dec 2022
Share Share
Months after executive exodus, Exicure shaves off 66% of staff

Months after executive exodus, Exicure shaves off 66% of staff
Max Bayer FIERCEBIOTECH
27 Sep 2022
Share Share